Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a report released on Wednesday, Benzinga reports. They currently have a $65.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 52.19% from the company’s current price. […]
Polar Capital Holdings Plc reduced its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during the period. Polar […]